| 门冬胰岛素30与口服降糖药治疗2型糖尿病的成本-效果分析 |
| |
| 引用本文： | 李晔萍,郭连宇.门冬胰岛素30与口服降糖药治疗2型糖尿病的成本-效果分析[J].中国药师,2010,13(3):413-414. |
| |
| 作者姓名： | 李晔萍 郭连宇 |
| |
| 作者单位： | 卫生部及天津市激素与发育重点实验室,天津医科大学代谢病医院,天津,300070 |
| |
| 摘 要： | 目的：探讨门冬胰岛素30与口服降糖药治疗2型糖尿病的经济效果。方法：采用回顾性研究方法，选择165例2型糖尿病患者，随机分为3组（A组：门冬胰岛素30；B组：二甲双胍肠溶胶囊＋格列美脲片＋阿卡波糖片；C组：二甲双胍片＋格列关脲片＋瑞格列奈片）进行评价。结果：A、B、C3组成本分别为140．80，141．82，251．72元，总有效率分别为87．93％，79．25％，83．33％（P〉0．05），成本-效果比分别为1．60，1．79，3．02。结论：A组优于B和C组。
|
| 关 键 词： | 门冬胰岛素30 口服降糖药 2型糖尿病 成本-效果分析 |
Cost-effectiveness Analysis of NovoMix30FlexPen vs.Oral Hypoglycemic Drugs on Type 2 Diabetes Mellitus |
| |
| Li Yeping,Guo Lianyu.Cost-effectiveness Analysis of NovoMix30FlexPen vs.Oral Hypoglycemic Drugs on Type 2 Diabetes Mellitus[J].China Pharmacist,2010,13(3):413-414. |
| |
| Authors: | Li Yeping Guo Lianyu |
| |
| Institution: | (Key Lab of Hormone and Development, Metabolic Disease Hospital of Tianjin Medical University, Tianjin 300070, China) |
| |
| Abstract: | Objective： To evaluate the cost-effectiveness of NovoMix30FlexPen （Insulin-aspartate30） vs. oral hypoglycemic drugs on Type 2 diabetes meilitus. Method： A retrospective study was conducted in which a total of 165 cases with type 2 diabetes meilitus were devided into 3 group by random（ A ： NovoMix30FlexPen ; B ： Mefformin Hydrochloride Enteric-coated Capsules ＋ Glimepiride Tab- lets ＋ Acarbose Tablets ; C ： Mefformin Hydrocldoride Tablets ＋ Glimepiride Tablets ＋ Repaglinide Tablets） to be compared. Result： The cost was 140. 80 yuan in Group A versus 141.82 yuan in Group B vs. 251, 72 yuan in Group C; the total effective rates were 87. 93% versus 79. 25% versus 83.33% （P 〉0. 05） and the cost-effectiveness ratios were 1.60,1.79 and 3.02 respectively. Conclusion： Group A is superior to B and C groups for type 2 diabetes mellitus. |
| |
| Keywords: | Novo3OFlexPen Oral hypoglyeemic drug Type 2 diabetes mellitus Cost-effectiveness analysis |
| 本文献已被 维普 万方数据 等数据库收录！ |
